FacebookTwitterRedditEmail

Death By Tweetstorm: a Win-Win for Trump

Photograph by Nathaniel St. Clair

For lack of respirators, patients with severe respiratory distress from COVID-19 will die as the epidemic unfolds. A drug to treat the disease is urgently needed. But the US press subjected news about hydroxychloroquine, a potential treatment, to an excess of caution in response to a Trump tweetstorm. Journalists and health care professionals alike were whipsawed by the president’s irresponsible ballyhooing of the drug amid deprecatory assertions of “anecdotal” evidence by Anthony Fauci at the CDC.

This fast-moving story started picking up steam with results from a small trial of hydroxychloroquine to treat COVID-19 out of Marseilles, France, by a well-known infectious disease specialist, Didier Raoult. It follows upon another small study from China, also promising. The drug has been used to treat immune-related disease for more than 60 years. It deserves the serious consideration it’s getting from the Europeans and Chinese.

The French trial included 36 patients, 16 of whom were controls who did not receive the drug. The 20 remaining patients, all with confirmed COVID-19 infection, were treated with hydroxychloroquine for 14 days. Some were asymptomatic, others had symptoms. Six of the patients also received an antibiotic, azithromycin.

The striking result was diminished viral load in the treated patients. As Raoult and colleagues put it in their as-yet unpublished paper, “70% of hydroxychloroquine-treated patients were virologicaly cured comparing with 12.5% in the control group.” Although the mechanism of action with this virus is not known, it’s been biochemically well-characterized; it’s not snake oil.

In that context, Trump’s endorsement, laced with ignorance, made things worse. In response came Anthony Fauci’s March 20 mischaracterization of the data as “anecdotal.” He was soon more concessional in his comments but Trump’s words met their mark. The next day the New York Times reported that the drug was “being prescribed right and left.”

Trump’s tweets sewed confusion and nixed hopes for a rational scenario. Concern about insufficient supply, unruly demand, and hysteria are well-placed. A rational approach would have been for the government to ensure provision for hydroxychloroquine to coincide as much as possible with the certain-to-come spike in severe cases. On global stage, this is already happening.  Drug makers are ramping up production. Novartis says it’s donating up to 130 million doses of the drug to the global pandemic.

As with any potential treatment, results from a couple of small trials warrant caution. In the case of hydroxychloroquine, the drug has been around since 1955. It has well-known adverse effects in some patients — those with heart disease, for example. But its safety profile would not be a problem for most.

It should be added that calls for huge trials ahead of approving this drug are misplaced. Based on their results, Raoult and colleagues have calculated that just 48 patients would be required to further test hydroxychloroquine, 24 to receive the drug and 24 controls. That’s a small number, but large enough.  Eighty years ago, penicillin required just about 5 patients for the decision to scale up manufacture.

The news out of Raoult’s laboratory is possibly nothing, possibly game-changing; It could have given patients, doctors, and especially hospital administrators much-needed mental room for organization and thoughtful emergency planning. The drug could have been an antidote to fear that “the sky is falling,” as Cornelia Griggs wrote in The Times (Op-Ed, March 19). Now, as far as it concerns panic, it’s too late.

Trump’s tweetstorm about hydroxychloroquine during a medical emergency of historic proportion will cost lives. But for Trump himself, there’s no downside. If the drug works, he will cover himself in glory. If it doesn’t — well, his friend Fauci told you so.

More articles by:

John Galbraith Simmons is author, in collaboration with Justin A. Zivin MD, PhD, of tPA for Stroke: The Story of a Controversial Drug (Oxford Univ Press, 2010).

bernie-the-sandernistas-cover-344x550
Weekend Edition
March 27, 2020
Friday - Sunday
Rob Urie
Bailouts for the Rich, the Virus for the Rest of Us
Louis Proyect
Life and Death in the Epicenter
Paul Street
“I Will Not Kill My Mother for Your Stock Portfolio”
Jeffrey St. Clair
Roaming Charges: The Scum Also Rises
Pam Martens - Russ Martens
Stimulus Bill Allows Federal Reserve to Conduct Meetings in Secret; Gives Fed $454 Billion Slush Fund for Wall Street Bailouts
Jefferson Morley
Could the Death of the National Security State be a Silver Lining of COVID-19?
Ruth Hopkins
A Message For America from Brazil’s First Indigenous Congresswoman
Kathleen Wallace
The End of the Parasite Paradigm
Anthony DiMaggio
Misinformation and the Coronavirus: On the Dangers of Depoliticization and Social Media
Andrew Levine
Neither Biden Nor Trump: Imagine Cuomo
David Rosen
God’s Vengeance: the Christian Right and the Coronavirus
David Schultz
The Covid-19 Bailout: Another Failed Opportunity at Structural Change
Evaggelos Vallianatos
In the Grip of Disease
Edward Leer
Somebody Else’s World: An Interview with Kelly Reichardt
Robert Fisk
What Trump is Doing in the Middle East While You are Distracted by COVID-19
Daniel Warner
COVID-19: Health or Wealth?
Thomas Klikauer – Norman Simms
Corona in Germany: Hording and Authoritarianism
Ramzy Baroud
BJP and Israel: Hindu Nationalism is Ravaging India’s Democracy
Richard Moser
Russia-gate: the Dead But Undead
Ron Jacobs
Politics, Pandemics and Trumpism
Chris Gilbert
Letter From Catalonia: Alarming Measures
Richard Eskow
Seven Rules for the Boeing Bailout
Jonathan Carp
Coronavirus and the Collapse of Our Imaginations
Andrew Bacevich
The Coronavirus and the Real Threats to American Safety and Freedom
Peter Cohen
COVID-19, the Exponential Function and Human the Survival
César Chelala - Alberto Luis Zuppi
The Pope is Wrong on Argentina
James Preston Allen
Alexander Cockburn Meets Charles Bukowski at a Sushi Bar in San Pedro
Jérôme Duval
The Only Oxygen Cylinder Factory in Europe is Shut down and Macron Refuses to Nationalize It
Neve Gordon
Gaza Has Been Under Siege for Years. Covid-19 Could Be Catastrophic
Alvaro Huerta
To Survive the Coronavirus, Americans Should Learn From Mexicans
Prabir Purkayastha
Why the Coronavirus Pandemic Poses Fundamental Challenges to All Societies
Raouf Halaby
Fireside Chatterer Andrew Cuomo for President
Thomas Drake
The Sobering Realities of the American Dystopia
Negin Owliaei
Wash Your Hands…If You Have Water
Felice Pace
A New Threat to California’s Rivers:  Will the Rush to Develop Our Newest Water Source Destroy More Streams?
Ray Brescia
What 9/11 Can Teach Us About Responding to COVID-19
ADRIAN KUZMINSKI
The Covid-19 Opportunity
John Kendall Hawkins
An Age of Intoxication: Pick Your Poison
Kollibri terre Sonnenblume
The Propaganda Virus: Is Anyone Immune?
Nicky Reid
Fear and Loathing in Coronaville Volume 1: Dispatches From a Terrified Heartland
Nolan Higdon – Mickey Huff
Don’t Just Blame Trump for the COVID-19 Crisis: the U.S. Has Been Becoming a Failed State for Some Time
Susan Block
Coronavirus Spring
David Yearsley
Lutz Alone
CounterPunch News Service
Letter from Truthdig’s Editor-in-Chief Robert Scheer to the Publisher Zuade Kaufman
CounterPunch News Service
Statement From Striking Truthdig Workers
FacebookTwitterRedditEmail